Spirit III: A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the treatment of subjects with de novo Native Coronary Artery lesions
Study of: Additional information coming soon.
For more information about this study or the Interventional Cardiology Research program at the Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, please contact Carol Stone at 612-863-9124.
|